DePuy Synthes is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands. DePuy Orthopaedics designs, manufactures, markets and distributes products for reconstructing damaged or diseased joints and for repairing and reconstructing traumatic skeletal injuries. DePuy Spine products facilitate fusion of the spine and correction of spinal deformities, preserving motion of the spine and repairing bone fractures. DePuy is now operating from several countries, including the United Kingdom, Japan, France, Germany, Ireland and Australia. In many other countries, DePuy operates as a brand under the Johnson & Johnson Medical organization. DePuy is currently the subject of more than 11,000 lawsuits related to its recall of faulty hip replacement systems, which lawyers and industry analysts estimate will cost parent company Johnson & Johnson billions of dollars to resolve.
DePuy Synthes
Unlock to Claim this listing
Add / Modify Company
3.5
Overall Excellence Rating
Industry
HealthcareCategory
Health Care Products ManufacturingESG/Ethical Impact
DePuy Synthes ardently endeavors to minimize its environmental footprint, employing strategies like energy efficiency initiatives, responsible sourcing, and eco-friendly product designs. This commitment resonates with its goal to contribute to a healthier planet by reducing its carbon emissions, conserving resources, and fostering an environmentally conscious culture within its operations, thereby aligning its objectives with environmental preservation and sustainable growth.An unequivocal harbinger of positive social impact, DePuy Synthes channels its technological expertise to elevate patient care and societal well-being, with a focus on improving patient outcomes, addressing unmet medical needs, and engaging in community health initiatives. By fostering collaborations, supporting healthcare education, and actively participating in patient advocacy efforts, the company demonstrates its dedication to fostering a comprehensive approach to societal well-being and healthcare empowerment. DePuy Synthes’s approach to stakeholder engagement is characterized by inclusivity and collaboration, encompassing patients, healthcare professionals, employees, communities, and investors. This commitment fosters an environment of open dialogue, empathetic listening, and transparent communication, shaping the company’s strategies, aligning with societal aspirations, and highlighting its steadfast dedication to advancing healthcare innovation, patient well-being, and societal progress.DePuy Synthes’s ESG is firmly rooted in robust governance and ethics that embody transparency, integrity, and accountability, permeating its decision-making processes through a diverse and experienced board of directors, stringent compliance mechanisms, and ethical conduct that establish the company as a paragon of responsible corporate citizenship and ethical leadership within the healthcare industry.DePuy Synthes’s financial sustainability is integrally intertwined with its holistic ESG endeavors, as its financial growth aligns harmoniously with its ability to provide innovative healthcare solutions that resonate with patients, healthcare professionals, and investors alike. This recognition of responsible innovation and sustainable business practices translates into meaningful financial performance and enduring value creation.DePuy Synthes, a distinguished leader in orthopedic and neurological solutions, notably exemplifies an unwavering commitment to ESG sustainability that intricately interlaces with its core operations, emblematic of its steadfast dedication to ethical excellence, positive societal influence, and sustainable value creation. Through a comprehensive approach that resonates with patients, healthcare partners, and global stakeholders, DePuy Synthes mirrors a dynamic and transformative approach to advancing healthcare while upholding responsible business practices, echoing its commitment to leaving a lasting impact across the dimensions of ESG.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
$8,600,000,000.00
Website Traffic
Employee Rating
3.9
Customer Rating
4.2
Company Size
10000+
ESG Risk Rating
3